Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

拉米夫定治疗慢性乙型肝炎隔日给药方法及疗程的探讨

简光富,朱传林,孙文峰

Chinese Hepatology（2007）

Cited 1|Views4
No score
Abstract
拉米夫定是抗乙型肝炎病毒(HBV)主要药物之一,其疗效肯定,对HBV DNA抑制率达80%以上,为临床广泛应用,但停药后HBV DNA阳转高达40%,而长期应用易产生YMDD耐药.为寻求有效的给药方法及疗程,减少用药剂量和费用,减少耐药的发生,达到长期抑制HBV DNA的目的,本组对慢性乙型肝炎患者采用连续服用拉米夫定24周后,改为隔日给药,现报道如下.
More
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined